BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4403853)

  • 1. Spironolactone--a weak enzyme inducer in man.
    Taylor SA; Rawlins MD; Smith SE
    J Pharm Pharmacol; 1972 Jul; 24(7):578-9. PubMed ID: 4403853
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of chlorpromazine on drug metabolism.
    Stevenson IH; O'Malley K; Turnbull MJ; Ballinger BR
    J Pharm Pharmacol; 1972 Jul; 24(7):577-8. PubMed ID: 4403852
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of spironolactone on antipyrine metabolism in calves.
    Janus K; Suszycka J
    Res Vet Sci; 1996 Jul; 61(1):87-8. PubMed ID: 8819201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of flurbiprofen on the metabolism of antipyrine in man.
    Chalmers IM; Bell MA; Buchanan WW
    Ann Rheum Dis; 1973 Jan; 32(1):58-61. PubMed ID: 4539857
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired enzyme induction by rifampicin in the elderly.
    Twum-Barima Y; Finnigan T; Habash AI; Cape RD; Carruthers SG
    Br J Clin Pharmacol; 1984 May; 17(5):595-7. PubMed ID: 6733008
    [No Abstract]   [Full Text] [Related]  

  • 10. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
    Bakke OM; Bending M; Aarbakke J; Davies DS
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
    [No Abstract]   [Full Text] [Related]  

  • 11. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone and enzyme induction in patients with alcoholic cirrhosis.
    Miguet JP; Vuitton D; Thebault-Lucas A; Joanne C; Dhumeaux D
    Gastroenterology; 1980 May; 78(5 Pt 1):996-1000. PubMed ID: 7380205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired oxidation of antipyrine in stagnant loop rats.
    Aarbakke J
    Scand J Gastroenterol; 1977; 12(8):929-35. PubMed ID: 605352
    [No Abstract]   [Full Text] [Related]  

  • 14. Gross impairment of hepatic drug metabolism in a patient with chronic liver disease.
    Adjepon-Yamoah KK; Nimmo J; Prescott LF
    Br Med J; 1974 Nov; 4(5941):387-8. PubMed ID: 4425889
    [No Abstract]   [Full Text] [Related]  

  • 15. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenobarbital-induced drug metabolism in man.
    Kellermann G; Luyten-Kellermann M
    Toxicol Appl Pharmacol; 1977 Jan; 39(1):97-104. PubMed ID: 841576
    [No Abstract]   [Full Text] [Related]  

  • 17. A re-evaluation of intersubject variation in enzyme induction in man.
    Branch RA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):104-10. PubMed ID: 455871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of spironolactone on antipyrine metabolism in man.
    Huffman DH; Shoeman DW; Pentikäinen P; Azarnoff DL
    Pharmacology; 1973; 10(6):338-44. PubMed ID: 4593769
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.